Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kuniko Horie-Inoue

Showing results (61-70 of 97) with videos related to

Pageof 10
Sort By:
Journal of Human Genetics|June 15, 2007
Association of the HTRA1 gene variant with age-related macular degeneration in the Japanese populationKeisuke Mori, Kuniko Horie-Inoue, Masakazu Kohda, et al.
Cancer Science|November 17, 2019
RNA-binding protein NONO promotes breast cancer proliferation by post-transcriptional regulation of SKP2 and E2F8Kaori Iino, Yuichi Mitobe, Kazuhiro Ikeda, et al.
International Journal of Cancer|February 13, 2007
Increased expression of estrogen-related receptor alpha (ERRalpha) is a negative prognostic predictor in human prostate cancerTetsuya Fujimura, Satoru Takahashi, Tomohiko Urano, et al.
Journal of Bone and Mineral Metabolism|October 3, 2009
Association of HTRA1 promoter polymorphism with spinal disc degeneration in Japanese womenTomohiko Urano, Ken'ichiro Narusawa, Satomi Kobayashi, et al.
Cancer Letters|June 17, 2020
HIF1α inhibitor 2-methoxyestradiol decreases NRN1 expression and represses in vivo and in vitro growth of patient-derived testicular germ cell tumor spheroidsTakeshi Namekawa, Sachi Kitayama, Kazuhiro Ikeda, et al.
International Journal of Molecular Sciences|September 9, 2017
TRIM44 Is a Poor Prognostic Factor for Breast Cancer Patients as a Modulator of NF-κB SignalingHidetaka Kawabata, Kotaro Azuma, Kazuhiro Ikeda, et al.
Cancer Research|May 4, 2005
Estrogen receptor-binding fragment-associated antigen 9 is a tumor-promoting and prognostic factor for renal cell carcinomaTetsuo Ogushi, Satoru Takahashi, Takumi Takeuchi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2005
Estrogen-responsive finger protein as a new potential biomarker for breast cancerTakashi Suzuki, Tomohiko Urano, Tohru Tsukui, et al.
Cancer Research|March 28, 2020
PSF Promotes ER-Positive Breast Cancer Progression via Posttranscriptional Regulation of <i>ESR1</i> and <i>SCFD2</i>Yuichi Mitobe, Kaori Iino, Ken-Ichi Takayama, et al.
Molecular Endocrinology (Baltimore, Md.)|March 30, 2012
TACC2 is an androgen-responsive cell cycle regulator promoting androgen-mediated and castration-resistant growth of prostate cancerKen-ichi Takayama, Kuniko Horie-Inoue, Takashi Suzuki, et al.
Pageof 10

Showing results (61-70 of 97) with videos related to

Sort By:
Pageof 10
Journal of Human Genetics|June 15, 2007
Association of the HTRA1 gene variant with age-related macular degeneration in the Japanese populationKeisuke Mori, Kuniko Horie-Inoue, Masakazu Kohda, et al.
Cancer Science|November 17, 2019
RNA-binding protein NONO promotes breast cancer proliferation by post-transcriptional regulation of SKP2 and E2F8Kaori Iino, Yuichi Mitobe, Kazuhiro Ikeda, et al.
International Journal of Cancer|February 13, 2007
Increased expression of estrogen-related receptor alpha (ERRalpha) is a negative prognostic predictor in human prostate cancerTetsuya Fujimura, Satoru Takahashi, Tomohiko Urano, et al.
Journal of Bone and Mineral Metabolism|October 3, 2009
Association of HTRA1 promoter polymorphism with spinal disc degeneration in Japanese womenTomohiko Urano, Ken'ichiro Narusawa, Satomi Kobayashi, et al.
Cancer Letters|June 17, 2020
HIF1α inhibitor 2-methoxyestradiol decreases NRN1 expression and represses in vivo and in vitro growth of patient-derived testicular germ cell tumor spheroidsTakeshi Namekawa, Sachi Kitayama, Kazuhiro Ikeda, et al.
International Journal of Molecular Sciences|September 9, 2017
TRIM44 Is a Poor Prognostic Factor for Breast Cancer Patients as a Modulator of NF-κB SignalingHidetaka Kawabata, Kotaro Azuma, Kazuhiro Ikeda, et al.
Cancer Research|May 4, 2005
Estrogen receptor-binding fragment-associated antigen 9 is a tumor-promoting and prognostic factor for renal cell carcinomaTetsuo Ogushi, Satoru Takahashi, Takumi Takeuchi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2005
Estrogen-responsive finger protein as a new potential biomarker for breast cancerTakashi Suzuki, Tomohiko Urano, Tohru Tsukui, et al.
Cancer Research|March 28, 2020
PSF Promotes ER-Positive Breast Cancer Progression via Posttranscriptional Regulation of <i>ESR1</i> and <i>SCFD2</i>Yuichi Mitobe, Kaori Iino, Ken-Ichi Takayama, et al.
Molecular Endocrinology (Baltimore, Md.)|March 30, 2012
TACC2 is an androgen-responsive cell cycle regulator promoting androgen-mediated and castration-resistant growth of prostate cancerKen-ichi Takayama, Kuniko Horie-Inoue, Takashi Suzuki, et al.
Pageof 10